CCL3 correlates with the number of mood disturbances and personality changes in patients with Alzheimer's disease

Psychiatry Research

Volumn 176, Issue 2-3, 2010, Pages 261-264

  Geppert, Anita Malgorzata ^a   Losy, Jacek ^a   Przedpelska Ober, Elzbieta ^a   Kozubski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

AD; MIP 1 ; Noncognitive impairment

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADULT; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DETERIORATION; DISEASE SEVERITY; DYSPHORIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; EUPHORIA; FEMALE; HEADACHE; HUMAN; IRRITABILITY; MALE; MENTAL INSTABILITY; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; RATING SCALE; SEXUAL DYSFUNCTION; SOCIAL PROBLEM; SPONDYLOARTHROPATHY; SYMPTOM; VERTIGO;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; CHEMOKINE CCL3; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MOOD DISORDERS; PERSONALITY; PERSONALITY INVENTORY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77949773207     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.02.007     Document Type: Article

References (32)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue R., Mark R., Mackenzie I.R., McGeer P.L., O Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiology of Aging 2000, 21:383-421.
2. Bouhuys A.L., Flentge F., Oldehinkel A.J., van den Berg M.D. Potential psychosocial mechanisms linking depression to immune function in elderly subjects. Psychiatry Research 2004, 127(3):237-245.
3. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behavior in pre-clinical murine prion disease. Neuroscience, 2002, 112:7-11.
4. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of Β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. Journal of Neuroscience 2000, 20:558-567.
5. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. ß-amyloid stimulation of microglia and monocytes results in TNFα - dependent expression of inducible nitric oxide synthase and neuronal apoptosis. Journal of Neuroscience 2001, 21(4):1179-1188.
6. Conrrads V.M., Denollet J., De Clerck L.S., Stevens W.J., Bridts C., Vrints C.J. Type D personality is associated with increased levels of tumor necrosis factor (TND)- alpha and TNF-alpha receptors in chronic heart failure. International Journal of Cardiology 2006, 113(1):34-38.
7. Cotman C.W., Tenner A.J., Cummings B.J. Β-amyloid converts an acute phase injury response to chronic injury responses. Neurobiology of Aging 1996, 17:723-731.
8. De Simoni M.G., Sironi M., De Luigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebro-ventricular injection of interleukin 1 induces high circulating levels of interleukin 6. Journal of Experimental Medicine 1990, 171:1773-1778.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Minimental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research 1975, 12:189-198.
10. Grammas P., Samany P.G., Thirumangalakudi L. Thrombonin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implication for disease pathogenesis. Journal of Alzheimers Disease 2006, 9(1):51-58.
11. Heesen H., Tanabe S., Berman M.A., Yoshizava I., Luo Y., Kim R.J., Post T.W., Gerard C., Dorf M.E. Mouse astrocytes respond to the chemokines MCP-1 and KC but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MPC1 receptor. Journal of Neuroscience Research 1996, 45(4):382-391.
12. Man S.M., Ma Y.R., Shang D.S., Zhao W.D., Li B., Guo D.W., Fang W.G., Zhu L., Chen Y.H. Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiology of Aging 2007, 28(4):485-496.
13. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neuroscience Letters 1987, 79:195-200.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
15. McManus C.M., Liu S.J., Hahn M.T., Hua L.L., Brosnan C.F., Berman J.W., Lee S.S.C. Differential induction of chemokines in human microglia by type I and II interferons. Glia 2000, 29:273-280.
16. Meda L., Baron P., Prat E., Scarpini E., Scarlato G., Cassatella M.A., Rossi F. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid. Journal of Neuroimmunology 1999, 93:45-52.
17. Murphy P.M., Baggiolini M., Charo I.F., Herbert C.A., Horuk R., Hatsushima K., Miller L.H., Oppenheim J.J., Power C.A. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacological Reviews 2000, 52:145-176.
18. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer's disease: systemic review, meta-analysis, and metaregression analysis. Archives of General Psychiatry 2006, 63(5):530-538.
19. Reisberg B., Ferris S.H., Leon M.J., de Crook T. Global Deterioration Scale (GDS). Psychopharmacology Bulletin 1998, 24:661-663.
20. Rezaine P., Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microscopy Research and Technique 1999, 45:359-382.
21. Rezaine P., Trillo-Pazos G., Everall I.P. Expression of Β-chemokines and chemokine receptors in human fetal astrocyte and microglia co-culture: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
22. Rubin E.H., Morris J.C., Berg L. The progression of personality changes in patients with mild senile dementia of Alzheimer type. Journal of the American Geriatrics Society 1987, 35:721-725.
23. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnsos-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunisation with amyloid-beta attenuates Alzheimer-disease-like pathology in PDAPP mouse. Nature 1999, 400(6740):173-177.
24. Simard A.R., Souled D., Gowing G., Julien J.P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49(4):489-502.
25. Suarez E.C., Lewis J.G., Krishnan R.R., Young K.H. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolisacharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004, 29(9):1119-1128.
26. Sun J.H., Yang B., Donnelly D.F., Ca C., LaMotte R.H. MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. Journal of Neurophysiology 2006, 96(5):2189-2199.
27. Tanabe S., Heesen M., Berman M.A., Fischer M.B., Yoshizawa I., Luo Y., Dorf M.E. Murine astrocytes express a functional chemokine receptor. Journal of Neuroscience 1997, 17:6522-6526.
28. Wilcock D.M., Munireddy S.K., Rosenthal A., Ugen K.E., Gordon M.N., Morgan D. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiology of Disease 2004, 15(1):11-20.
29. Wisniewski H.M., Vorbrodt A.V., Wegiel J., Morys J., Lossinsky A.S. Ultrastructure of the cell forming amyloid fibers in Alzheimer disease and scrapie. American Journal of Medical Genetics 1990, 7(suppl):287-297.
30. World Health Organisation, 1992. ICD-10: International Classification of Desease and Health Related Problems, 10th revision. WHO, Geneva.
31. Xia M., Qin S., Wu L., Mackay C.R., Hyman B.T. Immunohistochemical study of the Β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. American Journal of Physiology 1998, 153(1):31-37.
32. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.